Dr. Rhodes is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
195 Albany St
New Brunswick, NJ 08901Phone+1 732-235-2465
Education & Training
University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2016 - 2019
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2013 - 2016
Stony Brook University Health Sciences Center School of MedicineClass of 2013
Certifications & Licensure
NY State Medical License 2019 - 2026
NJ State Medical License 2023 - 2025
PA State Medical License 2016 - 2019- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 54 citationsPirtobrutinib after a Covalent BTK Inhibitor in Chronic Lymphocytic Leukemia.Anthony R Mato, Jennifer A Woyach, Jennifer R Brown, Paolo Ghia, Krish Patel
The New England Journal of Medicine. 2023-07-06 - 24 citationsKinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127.Skye Montoya, Jessie Bourcier, Mark Noviski, Hao Lu, Meghan C Thompson
Science. 2024-02-02 - 83 citationsIron overload in patients with acute leukemia or MDS undergoing myeloablative stem cell transplantation.Philippe Armand, Haesook T. Kim, Joanna M Rhodes, Marie-Michele Sainvil, Corey Cutler
Biology of Blood and Marrow Transplantation. 2011-06-01
Abstracts/Posters
- Outcomes for Double Hit Lymphoma Patients Identified Via Routine Vs Selective Testing for MYC RearrangementJoanna M Rhodes, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Efficacy of Therapies Following Venetoclax Discontinuation in CLL: Focus on B-Cell Receptor Signal Transduction Inhibitors and Cellular TherapiesJoanna Rhodes, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Press Mentions
Vitamin D Boosts Treatment-Free Survival in Some CLL Patients, Study ShowsAugust 13th, 2024- Rhodes Assesses Toxicity Concerns for ABVD and Brentuximab Vedotin in cHLJune 29th, 2024
- Oncternal Therapeutics : Lee 2022 ASCO Poster Zilovertamab + Ibrutinib for MCL and CLLJune 7th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
